Activate Immunotherapy (Formerly Known As NovaRx)
6828 Nancy Ridge Drive, Suite 100
Activate Immunotherapy has evolved from almost twenty years of research, over $90 million of private funding, and several multi-national clinical studies. Originally founded in 1997 to commercialize the award-winning research of Dr. Habib Fakhrai and associates at the Sidney Kimmel Cancer Center in San Diego and at UCLA, Activate Immunotherapy has never wavered in its passion for utilizing the body's own extraordinarily powerful immune system to fight cancer, fundamentally change the course of the disease, and meaningfully extend and improve patient lives.
Activate Immunotherapy (formerly NovaRx) is a clinical-stage immuno-oncology company based in San Diego, California. Activate utilizes a novel approach for activating the body's immune system to recognize and destroy cancer cells.
Founders: Habib Fakrai and Emmet O’Neal III
CSO: Habib Fakhrai
CEO: Justin Murdock
COO: Todd M. Binder
CBO: Stella M. Sung, Ph.D.
CFO: Robert Davis